Covert macrovascular disease and early outcome after ischemic cerebrovascular events - Summary - MDSpire

Covert macrovascular disease and early outcome after ischemic cerebrovascular events

  • By

  • Priyanka Boettger

  • Linda Vollmann

  • Jamschid Sedighi

  • Hassan Hassan

  • Heinz Frederik Noll

  • Pascal Bauer

  • Tobias Braun

  • Michael Buerke

  • Heidrun Kraemer-Best

  • Martin Juenemann

  • Omar Alhaj Omar

  • Samuel Sossalla

  • June 8, 2026

  • 0 min

Share

Objective:

Emphasize the significance of CMVD in ischemic stroke.

Key Findings:
  • Add implications of findings.
Interpretation:

Elaborate on clinical practice implications.

Limitations:
  • Include potential biases in observational studies.
Conclusion:

Suggest specific areas for future research.

Original Source(s)

Covert macrovascular disease and early outcome after ischemic cerebrovascular events

  • by Priyanka Boettger, Linda Vollmann, Jamschid Sedighi, Hassan Hassan, Heinz Frederik Noll, Pascal Bauer, Tobias Braun, Michael Buerke, Heidrun Kraemer-Best, Martin Juenemann, Omar Alhaj Omar, Samuel Sossalla

  • June 8, 2026

Related Content

Anticoagulation in Device-Detected Atrial Fibrillation—Uncertainty and Heterogeneity in Value

Mass Spec Roundup: Ubiquitin, Pollutants, and Pain

Non-protein ubiquitination, cryogenic chemical mapping, wastewater antidepressants, and new molecular clues to post-stroke pain

  • June 10, 2026

  • 6 min
Napkin-ring sign plaques are associated with clinical outcome in patients with acute ischemic stroke after endovascular therapy